top of page
Synterex Blog
Featured Blogs
Search
Build vs Buy for AI Tools in Regulatory Documentation: How to Make the Right Decision
Explore the real costs, risks, and ROI of building versus buying an AI-powered regulatory documentation system—and why a hybrid approach often wins
Jeanette Towles
2 days ago
Pharma Scale-Back in the United Kingdom: What It Means for UK Pharmaceutical Regulation
In 2025, several major pharmaceutical companies — including MSD (Merck), AstraZeneca, and Eli Lilly — have scaled back or cancelled planned investments in the UK. Decisions have ranged from pausing vaccine-manufacturing expansions to abandoning research center projects.
Jeanette Towles
Oct 2
bottom of page